DOYLESTOWN, Pa., Aug. 02, 2017 -- Alamo Pharma Services, Inc. (“Alamo”) is pleased to announce that its Chief Operating Officer, Peter Marchesini, has been named to PharmaVOICE magazine’s annual list of 100 most inspiring people in the life sciences industry for the second time. Marchesini previously received this prestigious distinction in 2009. Individuals named to PharmaVOICE 100 are leaders who drive the industry forward and inspire others through their innovative contributions and effective leadership style. Because PharmaVOICE 100 is a peer-nominated award, receipt of the award validates that others in the industry recognize Marchesini’s contributions.
|
||||||||
The two-time honoree with more than 25 years’ experience in the pharmaceutical industry, Marchesini, was recognized for his innovative problem-solving, creative customer solutions, and effective leadership style at Alamo, helping build Alamo into the successful company it is today.
Since being established in 2011, Alamo has made numerous positive contributions to the life sciences industry by providing clients with innovative, customized contract sales solutions. When Alamo was founded, Marchesini set out to identify talented individuals to join the organization, making a point to know the strengths and different professional backgrounds of each person along with their motivations and values. Since then, he has built a highly skilled team that is based on trust, accountability, and team spirit. Aware of working in an ever-changing industry, he strives to identify creative ways to keep his employees engaged. He also regularly challenges and supports his team, helping each person grow as professionals and as a collective to sharpen the company’s competitive edge.
As Chief Operating Officer, Marchesini views challenges as opportunities. When a customer comes to Alamo with a perceived obstacle to overcome, Marchesini finds a creative, innovative business strategy to meet that challenge, and the outcomes provide measurable results. Those who work with Marchesini recognize him as being not only a person who implements creative solutions but also someone who follows through on his commitments, is loyal, and giving.
Marchesini’s influence extends beyond Alamo and its customers. For several years now, Marchesini has been on the faculty at Rutgers Business School, where he co-teaches a core course of the Pharmaceutical MBA program called Managing the Pharmaceutical Sales Force. He goes past classroom expectations, assisting and mentoring both current students and those who have already graduated.
“Pete is known as someone who provides customers with creative, strategic solutions to problems that others may believe are hard to solve. More so, his customers know he is true to his word and through his leadership, Alamo delivers results – often beyond the client’s expectations,” says Alamo President and two-time PharmaVOICE 100 recipient, Terry Herring. This year Herring received the Red Jacket Award, a distinction earned by a select few who have received multiple PharmaVOICE 100 honors and then been peer nominated for their continued contributions to the life sciences industry. “Being an engaging leader, Pete shares his creative approach to solving problems with team members at Alamo and fosters a supportive environment. His leadership style has helped form a truly talented team of individuals dedicated to the results of their many clients.”
More than 10 years ago, PharmaVOICE magazine created the PharmaVOICE 100, an annual list of 100 individuals honored for their positive impact on the life sciences industry. Several thousand are nominated but only 100 individuals receive the honor. Recipients are selected based on substantive accounts that demonstrate how they have inspired or motivated their colleagues, peers, and competitors; have positively contributed to their own companies; and have given back to their communities and other philanthropic causes.
To view the complete PharmaVOICE 100 profile for Marchesini, please visit the July/August 2017 online digital edition at pharmavoice.com/current-issue/?issue=214.
Founded in 2011, Alamo Pharma Services offers pharmaceutical and biotech companies vital solutions to bring their products to market efficiently and successfully. Based out of its offices in Doylestown, Pa., Alamo offers companies vast commercialization experience, customized recruiting of sales teams, superior training, and committed support services. For more information regarding Alamo, visit AlamoPharmaServices.com or email [email protected].
Alamo is a part of the Mission Family of Companies, a collection of wholly-owned subsidiaries created to diversify offerings and build forward-thinking partnerships with other pharmaceutical and biotech companies. Each company functions independently while their product and service offerings can be linked together to offer customizable solutions to a wide array of outside companies. Other Mission companies include BioComp Pharma, Inc., a generic drug marketer; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a prescription and esthetic dermatology company; as well as BexR Logistix, LLC and their subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of Mission. To learn more, please visit www.missionfamilyofcompanies.com.
# # #
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/802606bf-cfdc-4a6b-8bd7-6c29ca07eac0
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/30c2e455-9d48-4788-8fa0-d267979f6847
Drew Deeter Alamo Pharma Services 215.348.3890 [email protected]


Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 



